Blue Horizon, a pure play impact investor in the future of food, has made a seed investment in a sustainable ingredients company producing protein from carbon dioxide.
Arkeon Biotechnologies is an ingredients company based in Vienna, Austria, leveraging the power of ancient microbes to create the most sustainable, nutritious, and ethical food system possible. Arkeon’s proprietary technology allows the company to convert CO2 directly into all 20 amino acids that are essential for the human diet, enabling an entirely new world of food products.
The company’s technological foundations have been built over a decade of research by co-founders Dr Simon Rittmann, Dr Guenther Bochmann, and Dr Gregor Tegl.
Blue Horizon has several investments in precision fermentation companies, including Motif FoodWorks, Geltor, Impossible Foods, The Every Company, AgBiome, and Chromologics. Other investors in Arkeon Biotechnologies’ EUR 7 million seed round include EVIG, Synthesis Capital, and ReGen Ventures.
